Uncertainties regarding NIH funding are causing negative impacts across the biotech industry, affecting sales, opportunities, and capital purchases in US academic labs.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Uncertainties regarding NIH funding are causing negative impacts across the biotech industry, affecting sales, opportunities, and capital purchases in US academic labs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- NIH funding shifts are impacting research operations at Scripps Research.Sub-event
NIH funding issues are causing headwinds for the broader biotech sector and US academic labs.1 source
Keep exploring
The entities involved
-
National Institutes of Health
government organization in Shah Alam, Malaysia
Related events
- NIH is funding research conducted by the National Cancer Institute (NCI) toward an FDA Investigational New Drug (IND) application.
- NIH, NSF, and NASA provided active funding to University of Hawaii research on October 29, 2026.
- NIH funded pivotal research for drug development involving Vertex Pharmaceuticals.
- The Trump administration seeks greater control over NIH grantmaking, while Susan Collins objects to the Office of Management and Budget's involvement.
Coverage
Newest first; wire copies grouped- GuruFocus.comQuantum-Si Inc (QSI) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing New ... Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the fu